

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | immunoglobulin mediated immune response (GO:0016064) | 6.27681627 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.44263765 |
| 3 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 5.27311593 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.23989227 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.97907253 |
| 6 | B cell mediated immunity (GO:0019724) | 4.86862124 |
| 7 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.81802772 |
| 8 | detection of other organism (GO:0098543) | 4.70772259 |
| 9 | detection of bacterium (GO:0016045) | 4.68758993 |
| 10 | neutrophil activation involved in immune response (GO:0002283) | 4.64887860 |
| 11 | regulation of antigen processing and presentation (GO:0002577) | 4.63112241 |
| 12 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.60414036 |
| 13 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.59337406 |
| 14 | negative regulation of cell killing (GO:0031342) | 4.55721416 |
| 15 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.55721416 |
| 16 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.36451916 |
| 17 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.29976888 |
| 18 | modulation by symbiont of host immune response (GO:0052553) | 4.29976888 |
| 19 | positive regulation by symbiont of host defense response (GO:0052509) | 4.29976888 |
| 20 | modulation by symbiont of host defense response (GO:0052031) | 4.29976888 |
| 21 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.29976888 |
| 22 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.29976888 |
| 23 | response to peptidoglycan (GO:0032494) | 4.26447473 |
| 24 | positive regulation of antigen processing and presentation (GO:0002579) | 4.26256744 |
| 25 | macrophage activation involved in immune response (GO:0002281) | 4.26088313 |
| 26 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.25103087 |
| 27 | B cell receptor signaling pathway (GO:0050853) | 4.21047333 |
| 28 | positive thymic T cell selection (GO:0045059) | 4.18834963 |
| 29 | detection of external biotic stimulus (GO:0098581) | 3.95959769 |
| 30 | regulation of gamma-delta T cell activation (GO:0046643) | 3.88180027 |
| 31 | negative regulation of interleukin-12 production (GO:0032695) | 3.86613685 |
| 32 | T-helper 1 type immune response (GO:0042088) | 3.82265433 |
| 33 | positive regulation of B cell differentiation (GO:0045579) | 3.81711610 |
| 34 | positive regulation of mast cell activation (GO:0033005) | 3.76392784 |
| 35 | cellular response to interferon-gamma (GO:0071346) | 3.71831427 |
| 36 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.63404887 |
| 37 | positive regulation of mast cell degranulation (GO:0043306) | 3.63404887 |
| 38 | regulation of mast cell degranulation (GO:0043304) | 3.59233167 |
| 39 | defense response to protozoan (GO:0042832) | 3.58117199 |
| 40 | T cell costimulation (GO:0031295) | 3.57781767 |
| 41 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.57531136 |
| 42 | lymphocyte costimulation (GO:0031294) | 3.52396524 |
| 43 | positive regulation of type 2 immune response (GO:0002830) | 3.46898658 |
| 44 | detection of biotic stimulus (GO:0009595) | 3.46504278 |
| 45 | cellular response to type I interferon (GO:0071357) | 3.40794217 |
| 46 | type I interferon signaling pathway (GO:0060337) | 3.40794217 |
| 47 | detection of molecule of bacterial origin (GO:0032490) | 3.39479946 |
| 48 | response to type I interferon (GO:0034340) | 3.37674265 |
| 49 | regulation of B cell differentiation (GO:0045577) | 3.35775349 |
| 50 | response to interferon-gamma (GO:0034341) | 3.34750975 |
| 51 | regulation of mast cell activation (GO:0033003) | 3.33459304 |
| 52 | myeloid cell activation involved in immune response (GO:0002275) | 3.32509073 |
| 53 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.29670407 |
| 54 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.29168786 |
| 55 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.28711305 |
| 56 | response to protozoan (GO:0001562) | 3.25601028 |
| 57 | microglial cell activation (GO:0001774) | 3.20691559 |
| 58 | myeloid dendritic cell activation (GO:0001773) | 3.19051782 |
| 59 | positive T cell selection (GO:0043368) | 3.18426112 |
| 60 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.17853116 |
| 61 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.16863011 |
| 62 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.15938073 |
| 63 | response to muramyl dipeptide (GO:0032495) | 3.12886879 |
| 64 | germinal center formation (GO:0002467) | 3.12583276 |
| 65 | myeloid dendritic cell differentiation (GO:0043011) | 3.07649404 |
| 66 | cellular extravasation (GO:0045123) | 3.06492164 |
| 67 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.05969834 |
| 68 | regulation of T cell tolerance induction (GO:0002664) | 3.04981111 |
| 69 | negative thymic T cell selection (GO:0045060) | 3.04707006 |
| 70 | regulation of leukocyte degranulation (GO:0043300) | 3.04493481 |
| 71 | neutrophil activation (GO:0042119) | 3.03925124 |
| 72 | T cell selection (GO:0045058) | 3.03714510 |
| 73 | NIK/NF-kappaB signaling (GO:0038061) | 3.03494214 |
| 74 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.02291068 |
| 75 | respiratory burst (GO:0045730) | 3.01492122 |
| 76 | macrophage activation (GO:0042116) | 3.01269135 |
| 77 | granulocyte activation (GO:0036230) | 3.00622924 |
| 78 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.00198181 |
| 79 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.99533461 |
| 80 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.98230574 |
| 81 | positive regulation of interferon-alpha production (GO:0032727) | 2.96973396 |
| 82 | response to host immune response (GO:0052572) | 2.96766106 |
| 83 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.96766106 |
| 84 | regulation of interferon-alpha production (GO:0032647) | 2.93675353 |
| 85 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.93465334 |
| 86 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.93319445 |
| 87 | positive regulation of leukocyte degranulation (GO:0043302) | 2.93020111 |
| 88 | regulation of hypersensitivity (GO:0002883) | 2.88004534 |
| 89 | glycosphingolipid catabolic process (GO:0046479) | 2.85748853 |
| 90 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.85733220 |
| 91 | production of molecular mediator of immune response (GO:0002440) | 2.85640173 |
| 92 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.85622450 |
| 93 | regulation of tolerance induction (GO:0002643) | 2.85108800 |
| 94 | negative T cell selection (GO:0043383) | 2.83479038 |
| 95 | thymic T cell selection (GO:0045061) | 2.82705481 |
| 96 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.82356548 |
| 97 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.80752500 |
| 98 | T cell migration (GO:0072678) | 2.78046758 |
| 99 | positive regulation of macrophage cytokine production (GO:0060907) | 2.76314293 |
| 100 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.76225766 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.45468150 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.25893292 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.97168103 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.71982838 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.62508689 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.43477921 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.40753601 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.29902984 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.27915580 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.24638679 |
| 11 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.90149781 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.89506522 |
| 13 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.65793256 |
| 14 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.60037315 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.57889896 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.50983609 |
| 17 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.46678472 |
| 18 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.37886891 |
| 19 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.35510062 |
| 20 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.34287620 |
| 21 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.30707682 |
| 22 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.30702254 |
| 23 | MYB_26560356_Chip-Seq_TH2_Human | 2.28520408 |
| 24 | SPI1_23127762_ChIP-Seq_K562_Human | 2.23998043 |
| 25 | MYC_22102868_ChIP-Seq_BL_Human | 2.22871876 |
| 26 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.20558423 |
| 27 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.16940805 |
| 28 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.16611367 |
| 29 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.13338063 |
| 30 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.10061089 |
| 31 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.08131078 |
| 32 | MAF_26560356_Chip-Seq_TH1_Human | 2.01780854 |
| 33 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.97148447 |
| 34 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.96470220 |
| 35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.90926569 |
| 36 | MYB_26560356_Chip-Seq_TH1_Human | 1.90489748 |
| 37 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.87359040 |
| 38 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.77064086 |
| 39 | UTX_26944678_Chip-Seq_JUKART_Human | 1.68391499 |
| 40 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56550092 |
| 41 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.53523255 |
| 42 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.52461537 |
| 43 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.51280031 |
| 44 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.45474482 |
| 45 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44720084 |
| 46 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.41916546 |
| 47 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39019479 |
| 48 | MAF_26560356_Chip-Seq_TH2_Human | 1.37025791 |
| 49 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.35093936 |
| 50 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 1.34844590 |
| 51 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.34529728 |
| 52 | GATA1_22025678_ChIP-Seq_K562_Human | 1.33885544 |
| 53 | GATA3_26560356_Chip-Seq_TH2_Human | 1.31618569 |
| 54 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.30300904 |
| 55 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.29903183 |
| 56 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.29499706 |
| 57 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.28471905 |
| 58 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.27845062 |
| 59 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.27749507 |
| 60 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.24717114 |
| 61 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.23559687 |
| 62 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.21847312 |
| 63 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21683335 |
| 64 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.20531124 |
| 65 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.18835005 |
| 66 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18772239 |
| 67 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18068341 |
| 68 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17977419 |
| 69 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.17052044 |
| 70 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.15647544 |
| 71 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.13879903 |
| 72 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.13695270 |
| 73 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12809496 |
| 74 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.11654369 |
| 75 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.09780361 |
| 76 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.06977648 |
| 77 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.06121583 |
| 78 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.03896908 |
| 79 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.03409783 |
| 80 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02778450 |
| 81 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.99125276 |
| 82 | GATA1_19941826_ChIP-Seq_K562_Human | 0.97985483 |
| 83 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.95310873 |
| 84 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.94423343 |
| 85 | * STAT1_20625510_ChIP-Seq_HELA_Human | 0.93008564 |
| 86 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.92413488 |
| 87 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92216069 |
| 88 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89217177 |
| 89 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86130762 |
| 90 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83554002 |
| 91 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.81562899 |
| 92 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.81462685 |
| 93 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.79531806 |
| 94 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78266606 |
| 95 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.76406720 |
| 96 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.76217663 |
| 97 | P300_27268052_Chip-Seq_Bcells_Human | 0.75447619 |
| 98 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.74662494 |
| 99 | GATA2_19941826_ChIP-Seq_K562_Human | 0.71732783 |
| 100 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.70976568 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.83937212 |
| 2 | MP0003303_peritoneal_inflammation | 3.78823644 |
| 3 | MP0005671_abnormal_response_to | 3.60247937 |
| 4 | MP0003436_decreased_susceptibility_to | 3.41692137 |
| 5 | MP0003724_increased_susceptibility_to | 3.37320780 |
| 6 | MP0005387_immune_system_phenotype | 3.27539926 |
| 7 | MP0001790_abnormal_immune_system | 3.27539926 |
| 8 | MP0001800_abnormal_humoral_immune | 3.21787826 |
| 9 | MP0000685_abnormal_immune_system | 3.12766419 |
| 10 | MP0005000_abnormal_immune_tolerance | 3.02693798 |
| 11 | MP0002419_abnormal_innate_immunity | 2.84356154 |
| 12 | MP0002452_abnormal_antigen_presenting | 2.83660103 |
| 13 | MP0009785_altered_susceptibility_to | 2.79667551 |
| 14 | MP0002148_abnormal_hypersensitivity_rea | 2.76475332 |
| 15 | MP0006082_CNS_inflammation | 2.74650077 |
| 16 | MP0005025_abnormal_response_to | 2.73877173 |
| 17 | MP0002723_abnormal_immune_serum | 2.69094117 |
| 18 | MP0005058_abnormal_lysosome_morphology | 2.52901630 |
| 19 | MP0002420_abnormal_adaptive_immunity | 2.47669339 |
| 20 | MP0001819_abnormal_immune_cell | 2.45906615 |
| 21 | MP0003172_abnormal_lysosome_physiology | 2.17389604 |
| 22 | MP0010155_abnormal_intestine_physiology | 2.12080310 |
| 23 | MP0003300_gastrointestinal_ulcer | 2.08184735 |
| 24 | MP0003191_abnormal_cellular_cholesterol | 1.89000221 |
| 25 | MP0001845_abnormal_inflammatory_respons | 1.88231037 |
| 26 | MP0005464_abnormal_platelet_physiology | 1.87055346 |
| 27 | MP0000716_abnormal_immune_system | 1.86030585 |
| 28 | MP0003763_abnormal_thymus_physiology | 1.81759419 |
| 29 | MP0002398_abnormal_bone_marrow | 1.77657470 |
| 30 | MP0003183_abnormal_peptide_metabolism | 1.77404957 |
| 31 | MP0002405_respiratory_system_inflammati | 1.76422534 |
| 32 | MP0001533_abnormal_skeleton_physiology | 1.75807397 |
| 33 | MP0009840_abnormal_foam_cell | 1.73443722 |
| 34 | MP0002166_altered_tumor_susceptibility | 1.71779411 |
| 35 | MP0002138_abnormal_hepatobiliary_system | 1.69618433 |
| 36 | MP0004947_skin_inflammation | 1.61379367 |
| 37 | MP0005310_abnormal_salivary_gland | 1.61245499 |
| 38 | MP0009333_abnormal_splenocyte_physiolog | 1.59443147 |
| 39 | MP0001853_heart_inflammation | 1.55893706 |
| 40 | MP0009764_decreased_sensitivity_to | 1.55396593 |
| 41 | MP0002139_abnormal_hepatobiliary_system | 1.55177420 |
| 42 | MP0008469_abnormal_protein_level | 1.54872267 |
| 43 | MP0000689_abnormal_spleen_morphology | 1.54619145 |
| 44 | MP0003075_altered_response_to | 1.50718296 |
| 45 | MP0000604_amyloidosis | 1.46128489 |
| 46 | MP0002429_abnormal_blood_cell | 1.45538152 |
| 47 | MP0003806_abnormal_nucleotide_metabolis | 1.38778852 |
| 48 | MP0005451_abnormal_body_composition | 1.38200840 |
| 49 | MP0002722_abnormal_immune_system | 1.36340307 |
| 50 | MP0002998_abnormal_bone_remodeling | 1.35340159 |
| 51 | MP0005166_decreased_susceptibility_to | 1.31701619 |
| 52 | MP0003866_abnormal_defecation | 1.31602596 |
| 53 | MP0000858_altered_metastatic_potential | 1.28833854 |
| 54 | MP0000343_altered_response_to | 1.25460328 |
| 55 | MP0001873_stomach_inflammation | 1.24514496 |
| 56 | MP0005397_hematopoietic_system_phenotyp | 1.21659566 |
| 57 | MP0001545_abnormal_hematopoietic_system | 1.21659566 |
| 58 | MP0000465_gastrointestinal_hemorrhage | 1.21633494 |
| 59 | MP0008260_abnormal_autophagy | 1.20043004 |
| 60 | MP0009278_abnormal_bone_marrow | 1.17303563 |
| 61 | MP0002006_tumorigenesis | 1.11067195 |
| 62 | MP0003828_pulmonary_edema | 1.10143587 |
| 63 | MP0008004_abnormal_stomach_pH | 1.05483943 |
| 64 | MP0003690_abnormal_glial_cell | 1.01786510 |
| 65 | MP0004510_myositis | 0.96948232 |
| 66 | MP0005360_urolithiasis | 0.95072125 |
| 67 | MP0001663_abnormal_digestive_system | 0.94878347 |
| 68 | MP0004883_abnormal_blood_vessel | 0.94308889 |
| 69 | MP0003448_altered_tumor_morphology | 0.93854621 |
| 70 | MP0000703_abnormal_thymus_morphology | 0.92079165 |
| 71 | MP0002396_abnormal_hematopoietic_system | 0.90047367 |
| 72 | MP0009763_increased_sensitivity_to | 0.85455192 |
| 73 | MP0001851_eye_inflammation | 0.85092653 |
| 74 | MP0000249_abnormal_blood_vessel | 0.85022589 |
| 75 | MP0005365_abnormal_bile_salt | 0.82371599 |
| 76 | MP0000490_abnormal_crypts_of | 0.80338388 |
| 77 | MP0002132_abnormal_respiratory_system | 0.79760783 |
| 78 | MP0005164_abnormal_response_to | 0.73815778 |
| 79 | MP0002933_joint_inflammation | 0.73743779 |
| 80 | MP0005075_abnormal_melanosome_morpholog | 0.73452541 |
| 81 | MP0002136_abnormal_kidney_physiology | 0.67945136 |
| 82 | MP0000015_abnormal_ear_pigmentation | 0.66768379 |
| 83 | MP0005390_skeleton_phenotype | 0.64506877 |
| 84 | MP0000920_abnormal_myelination | 0.62600769 |
| 85 | MP0003091_abnormal_cell_migration | 0.61781770 |
| 86 | MP0003795_abnormal_bone_structure | 0.61582951 |
| 87 | MP0002009_preneoplasia | 0.61093093 |
| 88 | MP0005165_increased_susceptibility_to | 0.60707942 |
| 89 | MP0003045_fibrosis | 0.58913831 |
| 90 | MP0000609_abnormal_liver_physiology | 0.58524126 |
| 91 | MP0003656_abnormal_erythrocyte_physiolo | 0.58156714 |
| 92 | MP0009643_abnormal_urine_homeostasis | 0.56644107 |
| 93 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.55289930 |
| 94 | MP0005167_abnormal_blood-brain_barrier | 0.55180642 |
| 95 | MP0005085_abnormal_gallbladder_physiolo | 0.54387452 |
| 96 | MP0005381_digestive/alimentary_phenotyp | 0.53391282 |
| 97 | MP0005319_abnormal_enzyme/_coenzyme | 0.53271282 |
| 98 | MP0009765_abnormal_xenobiotic_induced | 0.52174800 |
| 99 | MP0008874_decreased_physiological_sensi | 0.51447838 |
| 100 | MP0004808_abnormal_hematopoietic_stem | 0.50652632 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent bacterial skin infections (HP:0005406) | 5.16625495 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.02458913 |
| 3 | Recurrent abscess formation (HP:0002722) | 4.98508237 |
| 4 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.82411772 |
| 5 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.82411772 |
| 6 | Abnormality of glycolipid metabolism (HP:0010969) | 4.82411772 |
| 7 | Abnormality of macrophages (HP:0004311) | 4.67892445 |
| 8 | Meningitis (HP:0001287) | 4.30319572 |
| 9 | Mediastinal lymphadenopathy (HP:0100721) | 4.25970885 |
| 10 | Agammaglobulinemia (HP:0004432) | 4.21177045 |
| 11 | Systemic lupus erythematosus (HP:0002725) | 4.13535892 |
| 12 | Obstructive lung disease (HP:0006536) | 3.88042365 |
| 13 | Chronic obstructive pulmonary disease (HP:0006510) | 3.88042365 |
| 14 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.83228368 |
| 15 | Vasculitis (HP:0002633) | 3.81006036 |
| 16 | Recurrent fungal infections (HP:0002841) | 3.75542990 |
| 17 | Increased cerebral lipofuscin (HP:0011813) | 3.69293711 |
| 18 | Recurrent skin infections (HP:0001581) | 3.68021885 |
| 19 | Gastrointestinal stroma tumor (HP:0100723) | 3.65123909 |
| 20 | Recurrent cutaneous fungal infections (HP:0011370) | 3.63055583 |
| 21 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.63055583 |
| 22 | Myositis (HP:0100614) | 3.61241330 |
| 23 | Pulmonary infiltrates (HP:0002113) | 3.53656556 |
| 24 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.44000407 |
| 25 | Colitis (HP:0002583) | 3.40088170 |
| 26 | Recurrent viral infections (HP:0004429) | 3.39756879 |
| 27 | Panhypogammaglobulinemia (HP:0003139) | 3.38274356 |
| 28 | Orchitis (HP:0100796) | 3.37098153 |
| 29 | Retrobulbar optic neuritis (HP:0100654) | 3.28183124 |
| 30 | Optic neuritis (HP:0100653) | 3.28183124 |
| 31 | Vacuolated lymphocytes (HP:0001922) | 3.25567123 |
| 32 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.25288466 |
| 33 | Cellulitis (HP:0100658) | 3.23500260 |
| 34 | Hemoptysis (HP:0002105) | 3.08806065 |
| 35 | Urticaria (HP:0001025) | 3.08725809 |
| 36 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.05079503 |
| 37 | Abnormality of the prostate (HP:0008775) | 3.04108078 |
| 38 | Dysostosis multiplex (HP:0000943) | 2.97806871 |
| 39 | Recurrent sinusitis (HP:0011108) | 2.97103310 |
| 40 | Inflammation of the large intestine (HP:0002037) | 2.96920395 |
| 41 | Encephalitis (HP:0002383) | 2.96905272 |
| 42 | Gastrointestinal infarctions (HP:0005244) | 2.94147480 |
| 43 | Restrictive lung disease (HP:0002091) | 2.93686774 |
| 44 | Stomatitis (HP:0010280) | 2.88378963 |
| 45 | Loss of speech (HP:0002371) | 2.83752050 |
| 46 | Chest pain (HP:0100749) | 2.83317975 |
| 47 | Gastrointestinal inflammation (HP:0004386) | 2.82533246 |
| 48 | Spontaneous hematomas (HP:0007420) | 2.80262901 |
| 49 | Osteomyelitis (HP:0002754) | 2.75979696 |
| 50 | Recurrent bronchitis (HP:0002837) | 2.75294856 |
| 51 | Autoimmune thrombocytopenia (HP:0001973) | 2.73019947 |
| 52 | Chronic diarrhea (HP:0002028) | 2.72535930 |
| 53 | Gingivitis (HP:0000230) | 2.68025584 |
| 54 | Lymphopenia (HP:0001888) | 2.64441628 |
| 55 | Increased IgE level (HP:0003212) | 2.60681847 |
| 56 | Abnormality of the pleura (HP:0002103) | 2.57952158 |
| 57 | Disinhibition (HP:0000734) | 2.56076093 |
| 58 | IgM deficiency (HP:0002850) | 2.54456420 |
| 59 | T lymphocytopenia (HP:0005403) | 2.54390106 |
| 60 | Glomerulonephritis (HP:0000099) | 2.53379112 |
| 61 | Recurrent pneumonia (HP:0006532) | 2.50026327 |
| 62 | Increased IgM level (HP:0003496) | 2.49489346 |
| 63 | Abnormality of T cell number (HP:0011839) | 2.47796807 |
| 64 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.46890853 |
| 65 | Pustule (HP:0200039) | 2.46871219 |
| 66 | Purpura (HP:0000979) | 2.45922776 |
| 67 | Emphysema (HP:0002097) | 2.37826860 |
| 68 | Pulmonary embolism (HP:0002204) | 2.37054726 |
| 69 | Keratoconjunctivitis sicca (HP:0001097) | 2.36524962 |
| 70 | Skin rash (HP:0000988) | 2.35216411 |
| 71 | Recurrent lower respiratory tract infections (HP:0002783) | 2.32063686 |
| 72 | Abnormality of T cells (HP:0002843) | 2.31209894 |
| 73 | Malnutrition (HP:0004395) | 2.30570787 |
| 74 | Petechiae (HP:0000967) | 2.29173815 |
| 75 | Epistaxis (HP:0000421) | 2.27272480 |
| 76 | Amyloidosis (HP:0011034) | 2.24445468 |
| 77 | Gangrene (HP:0100758) | 2.24189667 |
| 78 | Verrucae (HP:0200043) | 2.22224140 |
| 79 | Papilloma (HP:0012740) | 2.22224140 |
| 80 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.19182039 |
| 81 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.19182039 |
| 82 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.19182039 |
| 83 | Keratoconjunctivitis (HP:0001096) | 2.18825408 |
| 84 | Hypergammaglobulinemia (HP:0010702) | 2.17058774 |
| 85 | Polyneuropathy (HP:0001271) | 2.16557280 |
| 86 | Chronic otitis media (HP:0000389) | 2.15472215 |
| 87 | Leukocytosis (HP:0001974) | 2.14628143 |
| 88 | Pulmonary fibrosis (HP:0002206) | 2.13784780 |
| 89 | Mucopolysacchariduria (HP:0008155) | 2.13078132 |
| 90 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.13078132 |
| 91 | Sepsis (HP:0100806) | 2.12876701 |
| 92 | Arterial thrombosis (HP:0004420) | 2.10178204 |
| 93 | Abnormality of T cell physiology (HP:0011840) | 2.10024505 |
| 94 | Abnormality of B cell number (HP:0010975) | 2.07639307 |
| 95 | Viral hepatitis (HP:0006562) | 2.07161535 |
| 96 | Arthralgia (HP:0002829) | 2.06373718 |
| 97 | IgG deficiency (HP:0004315) | 2.03677651 |
| 98 | Acrocyanosis (HP:0001063) | 2.03378164 |
| 99 | Gingival bleeding (HP:0000225) | 2.02897667 |
| 100 | Hematochezia (HP:0002573) | 2.01602196 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.85561722 |
| 2 | MAP4K1 | 4.36062022 |
| 3 | BLK | 4.00214189 |
| 4 | TYK2 | 3.22774069 |
| 5 | ERN1 | 2.95133308 |
| 6 | MAP3K14 | 2.68248843 |
| 7 | BMPR2 | 2.53853032 |
| 8 | CSF1R | 2.44249387 |
| 9 | IRAK4 | 2.27128173 |
| 10 | PRPF4B | 2.26383079 |
| 11 | SYK | 2.24179617 |
| 12 | FES | 2.12592943 |
| 13 | MAP3K13 | 2.12514357 |
| 14 | TBK1 | 2.10167406 |
| 15 | CSK | 2.08370438 |
| 16 | BTK | 2.02583627 |
| 17 | KIT | 1.97685191 |
| 18 | JAK3 | 1.93053717 |
| 19 | IKBKE | 1.86713889 |
| 20 | TXK | 1.74068628 |
| 21 | LYN | 1.71943771 |
| 22 | IKBKB | 1.71153779 |
| 23 | ZAP70 | 1.69333224 |
| 24 | JAK1 | 1.65465256 |
| 25 | FGR | 1.47722570 |
| 26 | HCK | 1.46352955 |
| 27 | MAP2K3 | 1.45675001 |
| 28 | TEC | 1.42585005 |
| 29 | MATK | 1.37019032 |
| 30 | TNK2 | 1.34043981 |
| 31 | GRK6 | 1.33285353 |
| 32 | ITK | 1.31462185 |
| 33 | SIK3 | 1.30716640 |
| 34 | TAOK3 | 1.29263054 |
| 35 | CDK19 | 1.27340959 |
| 36 | GRK7 | 1.24029518 |
| 37 | LCK | 1.23373555 |
| 38 | MAP3K3 | 1.14831569 |
| 39 | JAK2 | 1.14268913 |
| 40 | CDC42BPA | 1.13675725 |
| 41 | TGFBR2 | 1.13274549 |
| 42 | TESK2 | 1.12626521 |
| 43 | NME2 | 1.00650556 |
| 44 | ACVR1B | 0.98736436 |
| 45 | SIK2 | 0.94386706 |
| 46 | MAP3K11 | 0.92003756 |
| 47 | MARK3 | 0.89943250 |
| 48 | IRAK3 | 0.87373585 |
| 49 | PDK1 | 0.83562929 |
| 50 | MAP3K1 | 0.82935272 |
| 51 | PRKCQ | 0.78154210 |
| 52 | MAP3K10 | 0.75669058 |
| 53 | TAOK2 | 0.74581287 |
| 54 | TAOK1 | 0.71936299 |
| 55 | MAPK7 | 0.71624560 |
| 56 | STK10 | 0.70753837 |
| 57 | PDPK1 | 0.69730039 |
| 58 | IRAK1 | 0.68164118 |
| 59 | MAPK12 | 0.66108602 |
| 60 | PIK3CG | 0.65674746 |
| 61 | CHUK | 0.63315219 |
| 62 | NEK9 | 0.60087797 |
| 63 | PIM1 | 0.58985549 |
| 64 | FYN | 0.58160533 |
| 65 | FGFR4 | 0.56156699 |
| 66 | FGFR3 | 0.54532049 |
| 67 | CDK6 | 0.54293088 |
| 68 | ABL1 | 0.53699539 |
| 69 | IRAK2 | 0.53424514 |
| 70 | YES1 | 0.47402262 |
| 71 | RIPK1 | 0.46980725 |
| 72 | EPHB1 | 0.46314281 |
| 73 | CDK4 | 0.46051329 |
| 74 | LRRK2 | 0.43389562 |
| 75 | MAPK11 | 0.43127207 |
| 76 | HIPK2 | 0.40198083 |
| 77 | MAP3K5 | 0.39770144 |
| 78 | MOS | 0.37955989 |
| 79 | KDR | 0.37438616 |
| 80 | MAPKAPK2 | 0.36971312 |
| 81 | RPS6KC1 | 0.36628256 |
| 82 | RPS6KL1 | 0.36628256 |
| 83 | MARK2 | 0.35203767 |
| 84 | PRKCD | 0.35119789 |
| 85 | TRPM7 | 0.34524183 |
| 86 | EGFR | 0.33897977 |
| 87 | MAPK4 | 0.32458501 |
| 88 | MAP2K2 | 0.32457686 |
| 89 | TRIB3 | 0.31113247 |
| 90 | STK24 | 0.30343100 |
| 91 | IGF1R | 0.29563833 |
| 92 | RPS6KA6 | 0.28704925 |
| 93 | DDR2 | 0.28497264 |
| 94 | MAP2K6 | 0.27728759 |
| 95 | INSR | 0.25075744 |
| 96 | PRKD2 | 0.24881795 |
| 97 | SMG1 | 0.24439246 |
| 98 | TLK1 | 0.23841899 |
| 99 | KSR2 | 0.23710194 |
| 100 | CAMKK2 | 0.23469775 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Asthma_Homo sapiens_hsa05310 | 4.71024963 |
| 2 | * Allograft rejection_Homo sapiens_hsa05330 | 4.48796449 |
| 3 | * Autoimmune thyroid disease_Homo sapiens_hsa05320 | 4.19099563 |
| 4 | * Graft-versus-host disease_Homo sapiens_hsa05332 | 4.17562545 |
| 5 | * Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.88486668 |
| 6 | * Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.69260862 |
| 7 | * Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.42070759 |
| 8 | * Leishmaniasis_Homo sapiens_hsa05140 | 3.19292873 |
| 9 | * Antigen processing and presentation_Homo sapiens_hsa04612 | 2.84373786 |
| 10 | * Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.77482252 |
| 11 | * Viral myocarditis_Homo sapiens_hsa05416 | 2.57289381 |
| 12 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.22960659 |
| 13 | * Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.19269567 |
| 14 | * Tuberculosis_Homo sapiens_hsa05152 | 2.05409624 |
| 15 | Other glycan degradation_Homo sapiens_hsa00511 | 2.03423376 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.98021805 |
| 17 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.97317827 |
| 18 | * Toxoplasmosis_Homo sapiens_hsa05145 | 1.80346131 |
| 19 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.77110703 |
| 20 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.54862767 |
| 21 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.54366537 |
| 22 | * Influenza A_Homo sapiens_hsa05164 | 1.53908802 |
| 23 | * Phagosome_Homo sapiens_hsa04145 | 1.52033328 |
| 24 | * Herpes simplex infection_Homo sapiens_hsa05168 | 1.44683004 |
| 25 | Lysosome_Homo sapiens_hsa04142 | 1.44225413 |
| 26 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.16515823 |
| 27 | Pertussis_Homo sapiens_hsa05133 | 1.16482661 |
| 28 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.11212765 |
| 29 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.08705575 |
| 30 | * Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.04987323 |
| 31 | * Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.02065367 |
| 32 | Measles_Homo sapiens_hsa05162 | 0.98614632 |
| 33 | Legionellosis_Homo sapiens_hsa05134 | 0.93247627 |
| 34 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.92263058 |
| 35 | Malaria_Homo sapiens_hsa05144 | 0.91935100 |
| 36 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.90537598 |
| 37 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.86867614 |
| 38 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.85355488 |
| 39 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.82820337 |
| 40 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.80312973 |
| 41 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.79900817 |
| 42 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.78352153 |
| 43 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.76726452 |
| 44 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.73886324 |
| 45 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.73404645 |
| 46 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.69798722 |
| 47 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.68151743 |
| 48 | Salmonella infection_Homo sapiens_hsa05132 | 0.67675391 |
| 49 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.65401714 |
| 50 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.62267136 |
| 51 | Hepatitis B_Homo sapiens_hsa05161 | 0.60265997 |
| 52 | Hepatitis C_Homo sapiens_hsa05160 | 0.60225590 |
| 53 | Apoptosis_Homo sapiens_hsa04210 | 0.59882624 |
| 54 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.56117221 |
| 55 | Platelet activation_Homo sapiens_hsa04611 | 0.55001765 |
| 56 | Shigellosis_Homo sapiens_hsa05131 | 0.52627288 |
| 57 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.52142876 |
| 58 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.45494844 |
| 59 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.45257461 |
| 60 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.45199290 |
| 61 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.41324661 |
| 62 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.31296381 |
| 63 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.31103435 |
| 64 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.28563734 |
| 65 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.26856959 |
| 66 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.26734298 |
| 67 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.25378253 |
| 68 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.24814766 |
| 69 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.24080448 |
| 70 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.23118043 |
| 71 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.22858560 |
| 72 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.22259747 |
| 73 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22089002 |
| 74 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.20566840 |
| 75 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.20133770 |
| 76 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.18874710 |
| 77 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.18698393 |
| 78 | Endocytosis_Homo sapiens_hsa04144 | 0.18508838 |
| 79 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.18010918 |
| 80 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.15939742 |
| 81 | Galactose metabolism_Homo sapiens_hsa00052 | 0.15896634 |
| 82 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.15018890 |
| 83 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.14549506 |
| 84 | Amoebiasis_Homo sapiens_hsa05146 | 0.14477508 |
| 85 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.14329761 |
| 86 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.13170377 |
| 87 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.12845684 |
| 88 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.12043760 |
| 89 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.10804858 |
| 90 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.10556406 |
| 91 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.10082620 |
| 92 | Mineral absorption_Homo sapiens_hsa04978 | 0.10060301 |
| 93 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.08549253 |
| 94 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.08413996 |
| 95 | Insulin resistance_Homo sapiens_hsa04931 | 0.08091324 |
| 96 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.06361507 |
| 97 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.05585553 |
| 98 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.05508897 |
| 99 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.03757744 |
| 100 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.03681788 |

